#AACR2025: Brenus Pharma presents late-breaking preclinical data on its “off-the-shelf” next-generation immunotherapy candidate, STC-1010, now moving to clinic
Brenus Pharma publishes promising proof of concept results of their therapeutic platform in the scientific Frontiers in Oncology journal
#AACR2024 Brenus Pharma unveils promising and robust pre-clinical efficacy extrapolating human conditions with STC-1010
Brenus Pharma unveils promising pre-clinical results extrapolating human conditions in major international congresses
#AACR2023 Brenus Pharma unveils groundbreaking preclinical results For STC-10101, a promising new drug candidate targeting colorectal cancer & solid tumors
